Page last updated: 2024-10-15

1-methyladenine

Description

1-methyladenine : Adenine substituted with a methyl group at position N-1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID135398646
CHEMBL ID304483
CHEBI ID18083
SCHEMBL ID1915
SCHEMBL ID1914
MeSH IDM0052241

Synonyms (44)

Synonym
einecs 225-907-0
6h-purin-6-imine, 1,9-dihydro-1-methyl-
98k2tg3e3w ,
nsc 70896
unii-98k2tg3e3w
CHEBI:18083 ,
nsc-70896
nsc70896
adenine, 1-methyl-
6h-purin-6-imine,9-dihydro-1-methyl-
wln: t56 bm dn fyn hnj fum h1
1h-purin-6-amine, 1-methyl-
1-methyl-1h-purin-6-amine
inchi=1/c6h7n5/c1-11-3-10-6-4(5(11)7)8-2-9-6/h2-3h,7h2,1h
1-methyladenine
5142-22-3
C02216
N1-METHYLADENINE ,
6h-purin-6-imine, 1, 9-dihydro-1-methyl-
1-methyl-9h-purin-6-imine
1-methyl-1h-purin-6-ylamine
CHEMBL304483
FT-0652731
A3702
AKOS006222775
AKOS015918483
FT-0635559
SCHEMBL1915
SCHEMBL1914
1-methyl-1h-purin-6-amine #
HPZMWTNATZPBIH-UHFFFAOYSA-N
DTXSID20199405
AS-58999
1, 9-dihydro-1-methyl-6h-purin-6-imine
1-methyl-adenine
CS-0059558
HY-113306
1-methyl-6-aminopurine
Q161642
Q63399494
D93477
1-methyl-7h-purin-6-imine
mfcd00010532
PD101955

Dosage Studied

ExcerptReference
" The 1-MeAde dose-response curves for maturation induction and activation of the histone H1 and RRLSSLRA kinases were superimposable."( Differential regulation of histone H1 and ribosomal S6 kinases during sea star oocyte maturation.
Krebs, EG; Meijer, L; Pelech, SL, 1987
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID155651Inhibition of Phosphatidylinositol 4-kinase at the ATP binding site (Inactive at 500 uM)1990Journal of medicinal chemistry, Aug, Volume: 33, Issue:8
Purine derivatives as competitive inhibitors of human erythrocyte membrane phosphatidylinositol 4-kinase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (155)

TimeframeStudies, This Drug (%)All Drugs %
pre-199068 (43.87)18.7374
1990's40 (25.81)18.2507
2000's27 (17.42)29.6817
2010's19 (12.26)24.3611
2020's1 (0.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews10 (6.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other147 (93.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]